EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Immune Infiltration in Invasive Lobular Breast Cancer.

Authors

Desmedt, Christine; Salgado, Roberto; Fornili, Marco; Pruneri, Giancarlo; Van den Eynden, Gert; Zoppoli, Gabriele; Rothé, Françoise; Buisseret, Laurence; Garaud, Soizic; Willard-Gallo, Karen; Brown, David; Bareche, Yacine; Rouas, Ghizlane; Galant, Christine; Bertucci, François; Loi, Sherene; Viale, Giuseppe; Di Leo, Angelo; Green, Andrew R.; Ellis, Ian O.

Abstract

<bold>Background: </bold>Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer after invasive ductal cancer (IDC). Here, we aimed at evaluating the prevalence, levels, and composition of tumor-infiltrating lymphocytes (TILs) and their association with clinico-pathological and outcome variables in ILC, and to compare them with IDC.<bold>Methods: </bold>We considered two patient series with TIL data: a multicentric retrospective series (n = 614) and the BIG 02-98 study (n = 149 ILC and 807 IDC). We compared immune subsets identified by immuno-histochemistry in the ILC (n = 159) and IDC (n = 468) patients from the Nottingham series, as well as the CIBERSORT immune profiling of the ILC (n = 98) and IDC (n = 388) METABRIC and The Cancer Genome Atlas patients. All ILC/IDC comparisons were done in estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative tumors. All statistical tests were two-sided.<bold>Results: </bold>TIL levels were statistically significantly lower in ILC compared with IDC (fold-change = 0.79, 95% confidence interval = 0.70 to 0.88, P < .001). In ILC, high TIL levels were associated with young age, lymph node involvement, and high proliferative tumors. In the univariate analysis, high TIL levels were associated with worse prognosis in the retrospective and BIG 02-98 lobular series, although they did not reach statistical significance in the latter. The Nottingham series revealed that the levels of intratumoral but not total CD8+ were statistically significantly lower in ILC compared with IDC. Comparison of the CIBERSORT profiles highlighted statistically significant differences in terms of immune composition.<bold>Conclusions: </bold>This study shows differences between the immune infiltrates of ER-positive/HER2-negative ILC and IDC in terms of prevalence, levels, localization, composition, and clinical associations.

Subjects

BREAST cancer treatment; BREAST cancer patients; CANCER chemotherapy; BREAST cancer diagnosis; CLINICAL pathology; BREAST tumor diagnosis; LYMPHOCYTE metabolism; PROTEIN metabolism; BREAST tumors; CELL receptors; COMPARATIVE studies; LYMPHOCYTES; RESEARCH methodology; MEDICAL cooperation; METASTASIS; PROGNOSIS; RESEARCH; EVALUATION research; RETROSPECTIVE studies; LYMPHOCYTE count; LOBULAR carcinoma

Publication

JNCI: Journal of the National Cancer Institute, 2018, Vol 110, Issue 7, p768

ISSN

0027-8874

Publication type

Academic Journal

DOI

10.1093/jnci/djx268

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved